These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31248649)

  • 1. A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.
    Barbour S; Djurdjev O; Gill JS; Dong JJ; Gill J
    Kidney Int; 2019 Aug; 96(2):460-469. PubMed ID: 31248649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol.
    Ibrahim H; Rogers T; Casingal V; Sturdevant M; Tan M; Humar A; Gillingham K; Matas A
    Transplantation; 2006 Jan; 81(2):214-9. PubMed ID: 16436965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of recurrence of primary glomerulonephritis on renal allograft outcome.
    Moroni G; Longhi S; Quaglini S; Rognoni C; Simonini P; Binda V; Montagnino G; Messa P
    Clin Transplant; 2014 Mar; 28(3):368-76. PubMed ID: 24757721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent and de novo glomerulonephritis following renal transplantation: higher rates of rejection and lower graft survival.
    Mirioglu S; Caliskan Y; Goksoy Y; Gulcicek S; Ozluk Y; Sarihan I; Seyahi N; Kilicaslan I; Turkmen A; Sever MS
    Int Urol Nephrol; 2017 Dec; 49(12):2265-2272. PubMed ID: 29039058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparity in kidney transplant survival relates to late rejection and is independent of steroid withdrawal.
    Liu A; Woodside KJ; Augustine JJ; Sarabu N
    Clin Transplant; 2018 Sep; 32(9):e13381. PubMed ID: 30098053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.
    Leeaphorn N; Garg N; Khankin EV; Cardarelli F; Pavlakis M
    Transpl Int; 2018 Feb; 31(2):175-186. PubMed ID: 28926143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.
    Hussain SM; Marcus RJ; Ko TY; Nashar K; Thai NL; Sureshkumar KK
    Exp Clin Transplant; 2016 Jun; 14(3):287-93. PubMed ID: 27221720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent glomerulonephritis under rapid discontinuation of steroids.
    Kukla A; Chen E; Spong R; Weber M; El-Shahawi Y; Gillingham K; Matas AJ; Ibrahim HN
    Transplantation; 2011 Jun; 91(12):1386-91. PubMed ID: 21508898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients.
    Taber DJ; Hunt KJ; Gebregziabher M; Srinivas T; Chavin KD; Baliga PK; Egede LE
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):131-139. PubMed ID: 27979979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early steroid withdrawal results in improved patient and graft survival and lower risk of post-transplant cardiovascular risk profiles: A single-center 10-year experience.
    Lopez-Soler RI; Chan R; Martinolich J; Park L; Ata A; Chandolias N; Conti DJ
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27888534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause.
    Lim WH; Wong G; McDonald SP; Chakera A; Luxton G; Isbel NM; Pilmore HL; Barbour T; Hughes P; Chadban SJ
    Sci Rep; 2018 Jun; 8(1):9021. PubMed ID: 29899355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alemtuzumab Induction and Steroid Minimization in IgA Nephropathy: A Matched-Cohort Analysis.
    Becker K; Brooks J; Mitro G; Rees M; Ortiz J
    Exp Clin Transplant; 2020 Dec; 18(7):751-756. PubMed ID: 31875465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of acute rejection vs recurrent glomerular disease with graft outcomes after kidney transplantation.
    Singh T; Astor BC; Zhong W; Mandelbrot DA; Maursetter L; Panzer SE
    Clin Transplant; 2019 Dec; 33(12):e13738. PubMed ID: 31630440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients.
    Meadows HB; Taber DJ; Pilch NA; Tischer SM; Baliga PK; Chavin KD
    Transplant Proc; 2012 Jun; 44(5):1323-8. PubMed ID: 22664009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal allograft survival in patients with oxalosis.
    Cibrik DM; Kaplan B; Arndorfer JA; Meier-Kriesche HU
    Transplantation; 2002 Sep; 74(5):707-10. PubMed ID: 12352890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year observational follow-up of a randomized trial comparing cyclosporine and tacrolimus therapy combined with steroid withdrawal in living-donor renal transplantation.
    Kim J; Park J; Hwang S; Yoo H; Kim K; Park JB; Jang HR; Lee JE; Kim SJ; Kim YG; Kim DJ; Oh HY; Huh W
    Clin Transplant; 2018 Sep; 32(9):e13372. PubMed ID: 30080284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid avoidance or withdrawal for kidney transplant recipients.
    Pascual J; Zamora J; Galeano C; Royuela A; Quereda C
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005632. PubMed ID: 19160257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes of Kidney Transplantation in Patients With Biopsy-Proven Glomerulonephritis.
    Park H; Park WY; Kang SS; Yeo SM; Han S; Park SB; Jin K
    Transplant Proc; 2018 May; 50(4):1009-1012. PubMed ID: 29731057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
    Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
    Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.